Summit Healthcare REIT Announces Sale of Skilled Nursing Facility Portfolio

Strategic Insights -

Summit Healthcare REIT, a publicly registered non-traded real estate investment trust (REIT), has announced the sale of a portfolio of three skilled nursing facilities in San Bernardino County, California. The portfolio, consisting of 191 licensed beds, was sold for $30,000,000 to affiliates of the current operator of the facilities. The sale yielded an internal rate of return (IRR) of over 50% for Summit, demonstrating the company's ability to execute its strategic plan and deliver value to its shareholders.

Key Takeaways:

  • Summit Healthcare REIT has sold a portfolio of three skilled nursing facilities in San Bernardino County, California, totaling 191 licensed beds, for $30,000,000.
  • The sale was conducted without the aid of an outside brokerage firm, indicating Summit's ability to negotiate effectively.
  • The transaction yielded an internal rate of return (IRR) of over 50% for Summit, demonstrating the company's successful execution of its strategic plan.
  • The sale is a testament to Summit's continued focus on investing in senior housing real estate, with a current portfolio of interests in 36 senior housing facilities across 11 states.
  • Chief Executive Officer Elizabeth Pagliarini mentioned that this sale is "another step in the right direction" for Summit and that she remains optimistic about the company's future prospects.

Statistics:

  • $30,000,000: the sale price of the skilled nursing facility portfolio.
  • 191: the total number of licensed beds in the portfolio sold.
  • 50%+: the internal rate of return (IRR) achieved by Summit on the sale of the portfolio.
  • 36: the number of senior housing facilities in Summit's current portfolio.
  • 11: the number of states in which Summit has interests in senior housing facilities.

Sources:

  • PRNewswire, September 11, 2024.
  • Summit Healthcare REIT, Inc. documents, including the annual report on Form 10-K for the year ended December 31, 2023, and the quarterly report for the periods ended March 31, 2024, and June 30, 2024.